EUVIMEDEUVIMED entdecken
Systematische Übersicht

Features and results availability of non-commercial Spanish COVID-19 trials: a systematic review of clinical trial registers and corresponding literature

Rafael Dal-Ré, Elena García-Méndez, Ignacio Mahillo-Fernández

European Journal of Clinical Pharmacology · 2025

DOI: 10.1007/s00228-024-03791-6 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, 2025. Verfasst von Rafael Dal-Ré und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Sp…. Hauptthemen laut MEDLINE: Registries, COVID-19, Clinical Trials as Topic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to characterize non-commercial Spanish COVID-19 trials and to determine the availability of results. Differences in outcomes according to the interventions assessed (medicines, non-medicines) will also be determined. METHODS: This systematic review was conducted in March 2024 by searching non-commercial Spanish COVID-19 trials on four registers (EUCTR, Clinical. TRIALS: gov, ISRCTN, DRKS) and the WHO ICTRP. Phase-1 medicines trials were excluded. Several variables were retrieved from registers. Publication of main trial results were searched on PubMed, Cochrane COVID-19 Study Register, and Google Scholar. Journals' impact factor and articles' citations on Google Scholar were also registered. Results from medicines and non-medicines trials extracted from registers and articles were compared. RESULTS: A total of 170 trials (57.1% medicines trials) were identified. These 170 trials were randomized (87.1%), masked (41.8%), or multicenter (39.4%); a total of 15,555 participants were enrolled, mostly in small trials (median, n = 88). Only 8.8% (15/170) of trials posted results on the registers; only 47.6% (81/170) of trials had either published results or posted them on registers. Publications accounted for 92.6% (75/81) of these. Articles were published in 56 different journals, had a median impact factor of 4.4 and a median of 10 citations. Most (58.7%, 44/75) described negative results. There were statistically significant differences (p < 0.001) between medicines and non-medicines trials on timely registration and on being multicenter. This was also the case among published trials with respect to negative results of the primary endpoint. CONCLUSION: Although most trials were randomized, a minority were multicenter, large, or masked. Trial results should be posted on the registers to make them accessible to everyone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesCOVID-19Clinical Trials as TopicHumansSpainCOVID-19 Drug TreatmentSARS-CoV-2

Stichwörter der Autor:innen

ArticlesCitationsClinicalTrials.govData sharingEU-CTRMedicines trialsNon-medicines trialsPreprintsRegistersSample size

Autor:innen und Institutionen

  • Biostatistics and Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain. rafael.dalre@quironsalud.es.
  • Technical Secretariat, Research Ethics Committee (CEIm), La Paz University Hospital. IdiPAZ (Hospital La Paz Institute for Health Research), Madrid, Spain.
  • Biostatistics and Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.

Zitieren

APA

Dal-Ré, R., García-Méndez, E., & Mahillo-Fernández, I. (2025). Features and results availability of non-commercial Spanish COVID-19 trials: a systematic review of clinical trial registers and corresponding literature. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03791-6

Vancouver

Dal-Ré R, García-Méndez E, Mahillo-Fernández I. Features and results availability of non-commercial Spanish COVID-19 trials: a systematic review of clinical trial registers and corresponding literature. European Journal of Clinical Pharmacology. 2025. doi:10.1007/s00228-024-03791-6

BibTeX
@article{DalR2025,
  author = {Dal-Ré, Rafael and García-Méndez, Elena and Mahillo-Fernández, Ignacio},
  title = {Features and results availability of non-commercial Spanish COVID-19 trials: a systematic review of clinical trial registers and corresponding literature},
  journal = {European Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1007/s00228-024-03791-6}
}
Kostenlos starten →